Delaware
|
|
83-0480694
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification Number)
|
Large accelerated filer
|
o
|
|
Accelerated filer
|
x
|
|
Non-accelerated filer
|
o
|
(Do not check if smaller reporting company)
|
Smaller reporting company
|
o
|
|
|
|
|
Emerging growth company
|
x
|
|
|
|
Page
|
|
|
|
Item 1.
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
Item 1.
|
||
Item 1A.
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
Item 5.
|
||
Item 6.
|
||
|
||
|
TRUPANION, INC.
Consolidated Statements of Operations
(in thousands, except share data)
(unaudited)
|
|||||||||||||||
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Revenue
|
$
|
78,164
|
|
|
$
|
63,118
|
|
|
$
|
221,316
|
|
|
$
|
176,122
|
|
Cost of revenue:
|
|
|
|
|
|
|
|
||||||||
Veterinary invoice expense
|
54,303
|
|
|
43,453
|
|
|
156,196
|
|
|
123,649
|
|
||||
Other cost of revenue
|
10,117
|
|
|
7,858
|
|
|
27,959
|
|
|
21,160
|
|
||||
Gross profit
|
13,744
|
|
|
11,807
|
|
|
37,161
|
|
|
31,313
|
|
||||
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
Technology and development
|
2,299
|
|
|
2,471
|
|
|
6,761
|
|
|
7,196
|
|
||||
General and administrative
|
4,174
|
|
|
4,017
|
|
|
13,242
|
|
|
12,274
|
|
||||
Sales and marketing
|
6,365
|
|
|
4,862
|
|
|
18,005
|
|
|
13,323
|
|
||||
Total operating expenses
|
12,838
|
|
|
11,350
|
|
|
38,008
|
|
|
32,793
|
|
||||
Operating income (loss)
|
906
|
|
|
457
|
|
|
(847
|
)
|
|
(1,480
|
)
|
||||
Interest expense
|
336
|
|
|
124
|
|
|
887
|
|
|
370
|
|
||||
Other (income) expense, net
|
(628
|
)
|
|
(99
|
)
|
|
(1,071
|
)
|
|
(1,239
|
)
|
||||
Income (loss) before income taxes
|
1,198
|
|
|
432
|
|
|
(663
|
)
|
|
(611
|
)
|
||||
Income tax (benefit) expense
|
(7
|
)
|
|
26
|
|
|
(11
|
)
|
|
54
|
|
||||
Net income (loss)
|
$
|
1,205
|
|
|
$
|
406
|
|
|
$
|
(652
|
)
|
|
$
|
(665
|
)
|
|
|
|
|
|
|
|
|
||||||||
Net income (loss) per share:
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
0.04
|
|
|
$
|
0.01
|
|
|
$
|
(0.02
|
)
|
|
$
|
(0.02
|
)
|
Diluted
|
$
|
0.03
|
|
|
$
|
0.01
|
|
|
$
|
(0.02
|
)
|
|
$
|
(0.02
|
)
|
Weighted average shares of common stock outstanding:
|
|
|
|
|
|
|
|
||||||||
Basic
|
33,129,416
|
|
|
30,037,282
|
|
|
31,376,239
|
|
|
29,500,958
|
|
||||
Diluted
|
36,385,360
|
|
|
33,113,981
|
|
|
31,376,239
|
|
|
29,500,958
|
|
TRUPANION, INC.
Consolidated Statements of Comprehensive Income (Loss)
(in thousands)
(unaudited)
|
|||||||||||||||
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Net income (loss)
|
$
|
1,205
|
|
|
$
|
406
|
|
|
$
|
(652
|
)
|
|
$
|
(665
|
)
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustments
|
77
|
|
|
193
|
|
|
(242
|
)
|
|
317
|
|
||||
Net unrealized gain on available-for-sale debt securities
|
—
|
|
|
1
|
|
|
—
|
|
|
9
|
|
||||
Other comprehensive income (loss), net of taxes
|
77
|
|
|
194
|
|
|
(242
|
)
|
|
326
|
|
||||
Comprehensive income (loss)
|
$
|
1,282
|
|
|
$
|
600
|
|
|
$
|
(894
|
)
|
|
$
|
(339
|
)
|
TRUPANION, INC.
Consolidated Balance Sheets
(in thousands, except share data)
|
|||||||
|
September 30, 2018
|
|
December 31, 2017
|
||||
Assets
|
(unaudited)
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
34,677
|
|
|
$
|
25,706
|
|
Short-term investments
|
39,422
|
|
|
37,590
|
|
||
Accounts and other receivables
|
31,985
|
|
|
20,367
|
|
||
Prepaid expenses and other assets
|
4,184
|
|
|
2,895
|
|
||
Total current assets
|
110,268
|
|
|
86,558
|
|
||
Restricted cash
|
1,400
|
|
|
600
|
|
||
Long-term investments, at fair value
|
3,545
|
|
|
3,237
|
|
||
Property and equipment, net
|
69,998
|
|
|
7,868
|
|
||
Intangible assets, net
|
8,084
|
|
|
4,972
|
|
||
Other long-term assets
|
6,580
|
|
|
2,624
|
|
||
Total assets
|
$
|
199,875
|
|
|
$
|
105,859
|
|
Liabilities and stockholders’ equity
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
2,163
|
|
|
$
|
2,716
|
|
Accrued liabilities and other current liabilities
|
12,006
|
|
|
7,660
|
|
||
Reserve for veterinary invoices
|
14,216
|
|
|
12,756
|
|
||
Deferred revenue
|
32,848
|
|
|
22,734
|
|
||
Total current liabilities
|
61,233
|
|
|
45,866
|
|
||
Long-term debt
|
8,604
|
|
|
9,324
|
|
||
Deferred tax liabilities
|
1,002
|
|
|
1,002
|
|
||
Other liabilities
|
1,174
|
|
|
1,233
|
|
||
Total liabilities
|
72,013
|
|
|
57,425
|
|
||
Stockholders’ equity:
|
|
|
|
||||
Common stock: $0.00001 par value, 100,000,000 shares authorized; 34,171,653 and 33,415,668 shares issued and outstanding at September 30, 2018; 30,778,796 and 30,121,496 shares issued and outstanding at December 31, 2017
|
—
|
|
|
—
|
|
||
Preferred stock: $0.00001 par value, 10,000,000 shares authorized; no shares issued and outstanding
|
—
|
|
|
—
|
|
||
Additional paid-in capital
|
217,833
|
|
|
134,511
|
|
||
Accumulated other comprehensive loss
|
(334
|
)
|
|
(92
|
)
|
||
Accumulated deficit
|
(83,436
|
)
|
|
(82,784
|
)
|
||
Treasury stock, at cost: 755,985 shares at September 30, 2018 and 657,300 shares at December 31, 2017
|
(6,201
|
)
|
|
(3,201
|
)
|
||
Total stockholders’ equity
|
127,862
|
|
|
48,434
|
|
||
Total liabilities and stockholders’ equity
|
$
|
199,875
|
|
|
$
|
105,859
|
|
|
Nine Months Ended September 30,
|
||||||
|
2018
|
|
2017
|
||||
Operating activities
|
|
|
|
||||
Net loss
|
$
|
(652
|
)
|
|
$
|
(665
|
)
|
Adjustments to reconcile net loss to cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
3,027
|
|
|
3,208
|
|
||
Stock-based compensation expense
|
3,553
|
|
|
2,564
|
|
||
Gain on sale of equity method investment
|
—
|
|
|
(1,036
|
)
|
||
Other, net
|
(237
|
)
|
|
243
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Accounts and other receivables
|
(11,592
|
)
|
|
(10,164
|
)
|
||
Prepaid expenses and other assets
|
(549
|
)
|
|
(297
|
)
|
||
Accounts payable, accrued liabilities, and other liabilities
|
3,849
|
|
|
2,122
|
|
||
Reserve for veterinary invoices
|
1,484
|
|
|
1,639
|
|
||
Deferred revenue
|
10,133
|
|
|
9,075
|
|
||
Net cash provided by operating activities
|
9,016
|
|
|
6,689
|
|
||
Investing activities
|
|
|
|
||||
Purchases of fixed maturity investment securities
|
(29,567
|
)
|
|
(20,704
|
)
|
||
Maturities of fixed maturity investment securities
|
27,405
|
|
|
15,878
|
|
||
Purchases of other investments
|
(3,000
|
)
|
|
—
|
|
||
Acquisition of lease intangibles, related to corporate real estate acquisition
|
(2,959
|
)
|
|
—
|
|
||
Proceeds from sale of equity method investment
|
—
|
|
|
1,402
|
|
||
Purchases of property and equipment
|
(55,856
|
)
|
|
(2,247
|
)
|
||
Other
|
(852
|
)
|
|
(2,762
|
)
|
||
Net cash used in investing activities
|
(64,829
|
)
|
|
(8,433
|
)
|
||
Financing activities
|
|
|
|
||||
Proceeds from public offering of common stock, net of offering costs
|
65,690
|
|
|
—
|
|
||
Proceeds from exercise of stock options
|
2,872
|
|
|
2,082
|
|
||
Shares withheld to satisfy tax withholding
|
(1,839
|
)
|
|
(1,170
|
)
|
||
Proceeds from exercise of warrants
|
300
|
|
|
—
|
|
||
Proceeds from debt financing, net of financing fees
|
9,189
|
|
|
2,420
|
|
||
Repayment of debt financing
|
(10,000
|
)
|
|
—
|
|
||
Other financing
|
(535
|
)
|
|
(412
|
)
|
||
Net cash provided by financing activities
|
65,677
|
|
|
2,920
|
|
||
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash, net
|
(93
|
)
|
|
436
|
|
||
Net change in cash, cash equivalents, and restricted cash
|
9,771
|
|
|
1,612
|
|
||
Cash, cash equivalents, and restricted cash at beginning of period
|
26,306
|
|
|
24,237
|
|
||
Cash, cash equivalents, and restricted cash at end of period
|
$
|
36,077
|
|
|
$
|
25,849
|
|
Supplemental disclosures
|
|
|
|
||||
Noncash investing and financing activities:
|
|
|
|
||||
Issuance of common stock for cashless exercise of warrants
|
$
|
3,000
|
|
|
$
|
—
|
|
Issuance of common stock for acquisition of corporate real estate
|
$
|
9,640
|
|
|
$
|
—
|
|
Purchases of property and equipment included in accounts payable and accrued liabilities
|
$
|
165
|
|
|
$
|
531
|
|
Property and equipment acquired under lease
|
$
|
917
|
|
|
$
|
689
|
|
Year ending December 31:
|
|
|
|
|
|
|
||
2018
|
|
|
|
|
|
$
|
497
|
|
2019
|
|
|
|
|
|
1,972
|
|
|
2020
|
|
|
|
|
|
1,224
|
|
|
2021
|
|
|
|
|
|
1,210
|
|
|
2022
|
|
|
|
|
|
1,173
|
|
|
2023
|
|
|
|
|
|
1,210
|
|
|
Thereafter
|
|
|
|
|
|
3,238
|
|
|
Total rental payments
|
|
|
|
|
|
$
|
10,524
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Basic earnings per share:
|
|
|
|
|
|
|
|
||||||||
Net income (loss)
|
$
|
1,205
|
|
|
$
|
406
|
|
|
$
|
(652
|
)
|
|
$
|
(665
|
)
|
Shares used in computation:
|
|
|
|
|
|
|
|
||||||||
Weighted average shares of common stock outstanding
|
33,129,416
|
|
|
30,037,282
|
|
|
31,376,239
|
|
|
29,500,958
|
|
||||
Basic earnings per share
|
$
|
0.04
|
|
|
$
|
0.01
|
|
|
$
|
(0.02
|
)
|
|
$
|
(0.02
|
)
|
|
|
|
|
|
|
|
|
||||||||
Diluted earnings per share:
|
|
|
|
|
|
|
|
||||||||
Net income (loss)
|
$
|
1,205
|
|
|
$
|
406
|
|
|
$
|
(652
|
)
|
|
$
|
(665
|
)
|
Shares used in computation:
|
|
|
|
|
|
|
|
||||||||
Weighted average shares of common stock outstanding
|
33,129,416
|
|
|
30,037,282
|
|
|
31,376,239
|
|
|
29,500,958
|
|
||||
Stock options
|
2,663,375
|
|
|
2,618,567
|
|
|
—
|
|
|
—
|
|
||||
Restricted stock awards and units
|
236,932
|
|
|
919
|
|
|
—
|
|
|
—
|
|
||||
Warrants
|
355,637
|
|
|
457,213
|
|
|
—
|
|
|
—
|
|
||||
Weighted average number of shares
|
36,385,360
|
|
|
33,113,981
|
|
|
31,376,239
|
|
|
29,500,958
|
|
||||
Diluted earnings per share
|
$
|
0.03
|
|
|
$
|
0.01
|
|
|
$
|
(0.02
|
)
|
|
$
|
(0.02
|
)
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||
Stock options
|
3,647
|
|
|
480,360
|
|
|
3,234,932
|
|
|
4,118,884
|
|
Restricted stock awards and restricted stock units
|
—
|
|
|
—
|
|
|
439,798
|
|
|
234,758
|
|
Warrants
|
—
|
|
|
—
|
|
|
480,000
|
|
|
810,000
|
|
|
Amortized
Cost |
|
Gross
Unrealized Holding Gains |
|
Gross
Unrealized Holding Losses |
|
Fair
Value |
||||||||
As of September 30, 2018
|
|
|
|
|
|
|
|
||||||||
Long-term investments:
|
|
|
|
|
|
|
|
||||||||
Foreign deposits
|
$
|
2,545
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,545
|
|
Municipal bond
|
1,000
|
|
|
—
|
|
|
—
|
|
|
1,000
|
|
||||
|
$
|
3,545
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,545
|
|
Short-term investments:
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury securities
|
$
|
6,646
|
|
|
$
|
—
|
|
|
$
|
(3
|
)
|
|
$
|
6,643
|
|
Certificates of deposit
|
439
|
|
|
1
|
|
|
—
|
|
|
440
|
|
||||
U.S. government funds
|
32,337
|
|
|
—
|
|
|
—
|
|
|
32,337
|
|
||||
|
$
|
39,422
|
|
|
$
|
1
|
|
|
$
|
(3
|
)
|
|
$
|
39,420
|
|
|
|
|
|
|
|
|
|
||||||||
|
Amortized
Cost |
|
Gross
Unrealized Holding Gains |
|
Gross
Unrealized Holding Losses |
|
Fair
Value |
||||||||
As of December 31, 2017
|
|
|
|
|
|
|
|
||||||||
Long-term investments:
|
|
|
|
|
|
|
|
||||||||
Foreign deposits
|
$
|
2,237
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,237
|
|
Municipal bond
|
1,000
|
|
|
—
|
|
|
—
|
|
|
1,000
|
|
||||
|
$
|
3,237
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,237
|
|
Short-term investments:
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury securities
|
$
|
5,783
|
|
|
$
|
—
|
|
|
$
|
(4
|
)
|
|
$
|
5,779
|
|
Certificates of deposit
|
690
|
|
|
1
|
|
|
—
|
|
|
691
|
|
||||
U.S. government funds
|
31,117
|
|
|
—
|
|
|
—
|
|
|
31,117
|
|
||||
|
$
|
37,590
|
|
|
$
|
1
|
|
|
$
|
(4
|
)
|
|
$
|
37,587
|
|
|
September 30, 2018
|
||||||
|
Amortized
Cost |
|
Fair
Value |
||||
Available-for-sale:
|
|
|
|
||||
Due after one year through five years
|
$
|
3,545
|
|
|
$
|
3,545
|
|
|
$
|
3,545
|
|
|
$
|
3,545
|
|
|
As of September 30, 2018
|
||||||||||||||
|
Fair Value
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Assets
|
|
|
|
|
|
|
|
||||||||
Restricted cash
|
$
|
1,400
|
|
|
$
|
1,400
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Money market funds
|
4,741
|
|
|
4,741
|
|
|
—
|
|
|
—
|
|
||||
Fixed maturities:
|
|
|
|
|
|
|
|
|
|||||||
Foreign deposits
|
2,545
|
|
|
2,545
|
|
|
—
|
|
|
—
|
|
||||
Municipal bond
|
1,000
|
|
|
—
|
|
|
1,000
|
|
|
—
|
|
||||
Investment in variable interest entity
|
3,000
|
|
|
—
|
|
|
—
|
|
|
3,000
|
|
||||
Total
|
$
|
12,686
|
|
|
$
|
8,686
|
|
|
$
|
1,000
|
|
|
$
|
3,000
|
|
|
|
|
|
|
|
|
|
||||||||
|
As of December 31, 2017
|
||||||||||||||
|
Fair Value
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Assets
|
|
|
|
|
|
|
|
||||||||
Restricted cash
|
$
|
600
|
|
|
$
|
600
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Money market funds
|
5,167
|
|
|
5,167
|
|
|
—
|
|
|
—
|
|
||||
Fixed maturities:
|
|
|
|
|
|
|
|
||||||||
Foreign deposits
|
2,237
|
|
|
2,237
|
|
|
—
|
|
|
—
|
|
||||
Municipal bond
|
1,000
|
|
|
—
|
|
|
1,000
|
|
|
—
|
|
||||
Total
|
$
|
9,004
|
|
|
$
|
8,004
|
|
|
$
|
1,000
|
|
|
$
|
—
|
|
|
|
|
|
|
|
August 9, 2018
|
|
Assumptions
|
|
|
|
|
|
Fair Value
|
|
Risk free interest rate
|
|
|
|
|
|
2.5
|
%
|
Expected volatility
|
|
|
|
|
|
36.72
|
%
|
Expected life (years)
|
|
|
|
|
|
1.88
|
|
Expected dividend yield
|
|
|
|
|
|
—
|
%
|
Building and improvements
|
|
|
|
|
|
$
|
46,379
|
|
Land and improvements
|
|
|
|
|
|
15,833
|
|
|
Lease-related intangible assets
|
|
|
|
|
|
2,959
|
|
|
|
Nine Months Ended September 30,
|
||||||
Subscription
|
|
2018
|
|
2017
|
||||
Reserve at beginning of year
|
|
$
|
11,059
|
|
|
$
|
8,538
|
|
Veterinary invoices during the period related to:
|
|
|
|
|
||||
Current year
|
|
139,504
|
|
|
113,833
|
|
||
Prior years
|
|
364
|
|
|
(85
|
)
|
||
Total veterinary invoice expense
|
|
139,868
|
|
|
113,748
|
|
||
Amounts paid during the period related to:
|
|
|
|
|
||||
Current year
|
|
128,233
|
|
|
104,501
|
|
||
Prior years
|
|
9,836
|
|
|
7,533
|
|
||
Total paid
|
|
138,069
|
|
|
112,034
|
|
||
Non-cash expenses
|
|
497
|
|
|
306
|
|
||
Reserve at end of period
|
|
$
|
12,361
|
|
|
$
|
9,946
|
|
|
|
Nine Months Ended September 30,
|
||||||
Other Business
|
|
2018
|
|
2017
|
||||
Reserve at beginning of year
|
|
$
|
1,697
|
|
|
$
|
983
|
|
Veterinary invoices during the period related to:
|
|
|
|
|
||||
Current year
|
|
16,632
|
|
|
10,074
|
|
||
Prior years
|
|
(304
|
)
|
|
(173
|
)
|
||
Total veterinary invoice expense
|
|
16,328
|
|
|
9,901
|
|
||
Amounts paid during the period related to:
|
|
|
|
|
||||
Current year
|
|
14,822
|
|
|
8,786
|
|
||
Prior years
|
|
1,348
|
|
|
789
|
|
||
Total paid
|
|
16,170
|
|
|
9,575
|
|
||
Non-cash expenses
|
|
—
|
|
|
—
|
|
||
Reserve at end of period
|
|
$
|
1,855
|
|
|
$
|
1,309
|
|
Subscription
|
As of September 30, 2018
|
||
Year of Occurrence
|
|
||
2016
|
$
|
408
|
|
2017
|
1,179
|
|
|
2018
|
10,774
|
|
|
|
$
|
12,361
|
|
Other Business
|
As of September 30, 2018
|
||
Year of Occurrence
|
|
||
2017
|
$
|
44
|
|
2018
|
1,811
|
|
|
|
$
|
1,855
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Veterinary invoice expense
|
$
|
153
|
|
|
$
|
101
|
|
|
$
|
421
|
|
|
$
|
260
|
|
Other cost of revenue
|
96
|
|
|
69
|
|
|
277
|
|
|
172
|
|
||||
Technology and development
|
58
|
|
|
57
|
|
|
167
|
|
|
166
|
|
||||
General and administrative
|
634
|
|
|
503
|
|
|
1,708
|
|
|
1,416
|
|
||||
Sales and marketing
|
358
|
|
|
165
|
|
|
980
|
|
|
550
|
|
||||
Total stock-based compensation
|
$
|
1,299
|
|
|
$
|
895
|
|
|
$
|
3,553
|
|
|
$
|
2,564
|
|
|
Number Of Options
|
|
Weighted Average Exercise Price per Share
|
|
Aggregate Intrinsic Value (in thousands)
|
|||||
Outstanding as of December 31, 2017
|
4,006,399
|
|
|
$
|
7.16
|
|
|
$
|
88,578
|
|
Granted
|
—
|
|
|
—
|
|
|
|
|||
Exercised
|
(695,452
|
)
|
|
4.19
|
|
|
22,213
|
|
||
Forfeited
|
(76,015
|
)
|
|
15.26
|
|
|
|
|||
Outstanding as of September 30, 2018
|
3,234,932
|
|
|
$
|
7.61
|
|
|
$
|
90,967
|
|
|
|
|
|
|
|
|||||
Exercisable as of September 30, 2018
|
2,666,951
|
|
|
$
|
5.88
|
|
|
$
|
79,606
|
|
|
Number of
Shares |
|
Weighted Average
Grant Date Fair Value per Share |
|||
Unvested shares as of December 31, 2017
|
256,842
|
|
|
$
|
4.77
|
|
Granted
|
339,856
|
|
|
28.33
|
|
|
Vested
|
(136,330
|
)
|
|
8.05
|
|
|
Forfeited
|
(20,570
|
)
|
|
28.25
|
|
|
Unvested shares as of September 30, 2018
|
439,798
|
|
|
$
|
22.20
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Revenue:
|
|
|
|
|
|
|
|
||||||||
Subscription business
|
$
|
67,421
|
|
|
$
|
56,493
|
|
|
$
|
192,805
|
|
|
$
|
159,363
|
|
Other business
|
10,743
|
|
|
6,625
|
|
|
28,511
|
|
|
16,759
|
|
||||
|
78,164
|
|
|
63,118
|
|
|
221,316
|
|
|
176,122
|
|
||||
Veterinary invoice expense:
|
|
|
|
|
|
|
|
||||||||
Subscription business
|
48,285
|
|
|
39,761
|
|
|
139,868
|
|
|
113,748
|
|
||||
Other business
|
6,018
|
|
|
3,692
|
|
|
16,328
|
|
|
9,901
|
|
||||
|
54,303
|
|
|
43,453
|
|
|
156,196
|
|
|
123,649
|
|
||||
Other cost of revenue:
|
|
|
|
|
|
|
|
||||||||
Subscription business
|
6,468
|
|
|
5,454
|
|
|
18,232
|
|
|
15,304
|
|
||||
Other business
|
3,649
|
|
|
2,404
|
|
|
9,727
|
|
|
5,856
|
|
||||
|
10,117
|
|
|
7,858
|
|
|
27,959
|
|
|
21,160
|
|
||||
Gross profit:
|
|
|
|
|
|
|
|
||||||||
Subscription business
|
12,668
|
|
|
11,278
|
|
|
34,705
|
|
|
30,311
|
|
||||
Other business
|
1,076
|
|
|
529
|
|
|
2,456
|
|
|
1,002
|
|
||||
|
13,744
|
|
|
11,807
|
|
|
37,161
|
|
|
31,313
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Technology and development
|
2,299
|
|
|
2,471
|
|
|
6,761
|
|
|
7,196
|
|
||||
General and administrative
|
4,174
|
|
|
4,017
|
|
|
13,242
|
|
|
12,274
|
|
||||
Sales and marketing:
|
|
|
|
|
|
|
|
||||||||
Subscription business
|
6,266
|
|
|
4,811
|
|
|
17,730
|
|
|
13,161
|
|
||||
Other business
|
99
|
|
|
51
|
|
|
275
|
|
|
162
|
|
||||
|
6,365
|
|
|
4,862
|
|
|
18,005
|
|
|
13,323
|
|
||||
Operating income (loss)
|
$
|
906
|
|
|
$
|
457
|
|
|
$
|
(847
|
)
|
|
$
|
(1,480
|
)
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
United States
|
$
|
63,517
|
|
|
$
|
50,506
|
|
|
$
|
178,957
|
|
|
$
|
141,946
|
|
Canada
|
14,647
|
|
|
12,612
|
|
|
42,359
|
|
|
34,176
|
|
||||
Total revenue
|
$
|
78,164
|
|
|
$
|
63,118
|
|
|
$
|
221,316
|
|
|
$
|
176,122
|
|
|
Nine Months Ended September 30,
|
||||||
|
2018
|
|
2017
|
||||
Total pets enrolled (at period end)
|
497,942
|
|
|
404,069
|
|
||
Total subscription pets enrolled (at period end)
|
416,527
|
|
|
359,102
|
|
||
Monthly average revenue per pet
|
$
|
54.06
|
|
|
$
|
51.67
|
|
Lifetime value of a pet (LVP)
|
$
|
714
|
|
|
$
|
701
|
|
Average pet acquisition cost (PAC)
|
$
|
157
|
|
|
$
|
141
|
|
Average monthly retention
|
98.61
|
%
|
|
98.61
|
%
|
|
Period Ended
|
||||||||||||||||||||||||||||||
|
Sept. 30, 2018
|
|
Jun. 30, 2018
|
|
Mar. 31, 2018
|
|
Dec. 31, 2017
|
|
Sept. 30, 2017
|
|
Jun. 30, 2017
|
|
Mar. 31, 2017
|
|
Dec. 31, 2016
|
||||||||||||||||
Total pets enrolled (at period end)
|
497,942
|
|
|
472,480
|
|
|
446,533
|
|
|
423,194
|
|
|
404,069
|
|
|
383,293
|
|
|
364,259
|
|
|
343,649
|
|
||||||||
Total subscription pets enrolled (at period end)
|
416,527
|
|
|
401,033
|
|
|
385,640
|
|
|
371,683
|
|
|
359,102
|
|
|
346,409
|
|
|
334,909
|
|
|
323,233
|
|
||||||||
Monthly average revenue per pet
|
$
|
54.55
|
|
|
$
|
53.96
|
|
|
$
|
53.62
|
|
|
$
|
53.17
|
|
|
$
|
52.95
|
|
|
$
|
51.47
|
|
|
$
|
50.50
|
|
|
$
|
49.17
|
|
Lifetime value of a pet (LVP)
|
$
|
714
|
|
|
$
|
732
|
|
|
$
|
727
|
|
|
$
|
727
|
|
|
$
|
701
|
|
|
$
|
654
|
|
|
$
|
637
|
|
|
$
|
631
|
|
Average pet acquisition cost (PAC)
|
$
|
155
|
|
|
$
|
150
|
|
|
$
|
165
|
|
|
$
|
184
|
|
|
$
|
151
|
|
|
$
|
143
|
|
|
$
|
128
|
|
|
$
|
133
|
|
Average monthly retention
|
98.61
|
%
|
|
98.64
|
%
|
|
98.63
|
%
|
|
98.63
|
%
|
|
98.61
|
%
|
|
98.57
|
%
|
|
98.58
|
%
|
|
98.60
|
%
|
|
Nine Months Ended September 30,
|
||||||
|
2018
|
|
2017
|
||||
Sales and marketing expense
|
$
|
18,005
|
|
|
$
|
13,323
|
|
Net of sign-up fee revenue
|
(1,933
|
)
|
|
(1,619
|
)
|
||
Excluding:
|
|
|
|
||||
Stock-based compensation expense
|
(980
|
)
|
|
(550
|
)
|
||
Other business segment sales and marketing expense
|
(275
|
)
|
|
(162
|
)
|
||
Net acquisition cost
|
$
|
14,817
|
|
|
$
|
10,992
|
|
|
Period Ended
|
||||||||||||||||||||||||||||||
|
Sept. 30, 2018
|
|
Jun. 30, 2018
|
|
Mar. 31, 2018
|
|
Dec. 31, 2017
|
|
Sept. 30, 2017
|
|
Jun. 30, 2017
|
|
Mar. 31, 2017
|
|
Dec. 31, 2016
|
||||||||||||||||
Sales and marketing expense
|
$
|
6,365
|
|
|
$
|
5,702
|
|
|
$
|
5,938
|
|
|
$
|
5,781
|
|
|
$
|
4,862
|
|
|
$
|
4,372
|
|
|
$
|
4,089
|
|
|
$
|
3,951
|
|
Net of sign-up fee revenue
|
(693
|
)
|
|
(624
|
)
|
|
(616
|
)
|
|
(550
|
)
|
|
(558
|
)
|
|
(517
|
)
|
|
(544
|
)
|
|
(526
|
)
|
||||||||
Excluding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Stock-based compensation expense
|
(358
|
)
|
|
(349
|
)
|
|
(273
|
)
|
|
(172
|
)
|
|
(165
|
)
|
|
(198
|
)
|
|
(187
|
)
|
|
(113
|
)
|
||||||||
Other business segment sales and marketing expense
|
(99
|
)
|
|
(88
|
)
|
|
(87
|
)
|
|
(56
|
)
|
|
(51
|
)
|
|
(63
|
)
|
|
(48
|
)
|
|
(62
|
)
|
||||||||
Net acquisition cost
|
$
|
5,215
|
|
|
$
|
4,641
|
|
|
$
|
4,962
|
|
|
$
|
5,003
|
|
|
$
|
4,088
|
|
|
$
|
3,594
|
|
|
$
|
3,310
|
|
|
$
|
3,250
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
|
(in thousands)
|
||||||||||||||
Revenue:
|
|
|
|
|
|
|
|
||||||||
Subscription business
|
$
|
67,421
|
|
|
$
|
56,493
|
|
|
$
|
192,805
|
|
|
$
|
159,363
|
|
Other business
|
10,743
|
|
|
6,625
|
|
|
28,511
|
|
|
16,759
|
|
||||
Total revenue
|
78,164
|
|
|
63,118
|
|
|
221,316
|
|
|
176,122
|
|
||||
Cost of revenue:
|
|
|
|
|
|
|
|
||||||||
Subscription business(1)
|
54,753
|
|
|
45,215
|
|
|
158,100
|
|
|
129,052
|
|
||||
Other business
|
9,667
|
|
|
6,096
|
|
|
26,055
|
|
|
15,757
|
|
||||
Total cost of revenue
|
64,420
|
|
|
51,311
|
|
|
184,155
|
|
|
144,809
|
|
||||
Gross profit:
|
|
|
|
|
|
|
|
||||||||
Subscription business
|
12,668
|
|
|
11,278
|
|
|
34,705
|
|
|
30,311
|
|
||||
Other business
|
1,076
|
|
|
529
|
|
|
2,456
|
|
|
1,002
|
|
||||
Total gross profit
|
13,744
|
|
|
11,807
|
|
|
37,161
|
|
|
31,313
|
|
||||
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
Technology and development(1)
|
2,299
|
|
|
2,471
|
|
|
6,761
|
|
|
7,196
|
|
||||
General and administrative(1)
|
4,174
|
|
|
4,017
|
|
|
13,242
|
|
|
12,274
|
|
||||
Sales and marketing(1)
|
6,365
|
|
|
4,862
|
|
|
18,005
|
|
|
13,323
|
|
||||
Total operating expenses
|
12,838
|
|
|
11,350
|
|
|
38,008
|
|
|
32,793
|
|
||||
Operating income (loss)
|
906
|
|
|
457
|
|
|
(847
|
)
|
|
(1,480
|
)
|
||||
Interest expense
|
336
|
|
|
124
|
|
|
887
|
|
|
370
|
|
||||
Other (income) expense, net
|
(628
|
)
|
|
(99
|
)
|
|
(1,071
|
)
|
|
(1,239
|
)
|
||||
Income (loss) before income taxes
|
1,198
|
|
|
432
|
|
|
(663
|
)
|
|
(611
|
)
|
||||
Income tax (benefit) expense
|
(7
|
)
|
|
26
|
|
|
(11
|
)
|
|
54
|
|
||||
Net income (loss)
|
$
|
1,205
|
|
|
$
|
406
|
|
|
$
|
(652
|
)
|
|
$
|
(665
|
)
|
|
|
|
|
|
(1) Includes stock-based compensation expense as follows:
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
|
(in thousands)
|
||||||||||||||
Cost of revenue
|
$
|
249
|
|
|
$
|
170
|
|
|
$
|
698
|
|
|
$
|
432
|
|
Technology and development
|
58
|
|
|
57
|
|
|
167
|
|
|
166
|
|
||||
General and administrative
|
634
|
|
|
503
|
|
|
1,708
|
|
|
1,416
|
|
||||
Sales and marketing
|
358
|
|
|
165
|
|
|
980
|
|
|
550
|
|
||||
Total stock-based compensation expense
|
$
|
1,299
|
|
|
$
|
895
|
|
|
$
|
3,553
|
|
|
$
|
2,564
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||
|
(as a percentage of revenue)
|
||||||||||
Revenue
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
Cost of revenue
|
82
|
|
|
81
|
|
|
83
|
|
|
82
|
|
Gross profit
|
18
|
|
|
19
|
|
|
17
|
|
|
18
|
|
Operating expenses:
|
|
|
|
|
|
|
|
||||
Technology and development
|
3
|
|
|
4
|
|
|
3
|
|
|
4
|
|
General and administrative
|
5
|
|
|
6
|
|
|
6
|
|
|
7
|
|
Sales and marketing
|
8
|
|
|
8
|
|
|
8
|
|
|
8
|
|
Total operating expenses
|
16
|
|
|
18
|
|
|
17
|
|
|
19
|
|
Operating income (loss)
|
1
|
|
|
1
|
|
|
—
|
|
|
(1
|
)
|
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Other (income) expense, net
|
(1
|
)
|
|
—
|
|
|
—
|
|
|
(1
|
)
|
Income (loss) before income taxes
|
2
|
|
|
1
|
|
|
—
|
|
|
—
|
|
Income tax (benefit) expense
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Net income (loss)
|
2
|
%
|
|
1
|
%
|
|
—
|
%
|
|
—
|
%
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||
|
(as a percentage of subscription revenue)
|
||||||||||
Subscription business revenue
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
Subscription business cost of revenue
|
81
|
|
|
80
|
|
|
82
|
|
|
81
|
|
Subscription business gross profit
|
19
|
%
|
|
20
|
%
|
|
18
|
%
|
|
19
|
%
|
|
Three Months Ended September 30,
|
|
% Change
|
|
Nine Months Ended September 30,
|
|
% Change
|
||||||||||||||
|
2018
|
|
2017
|
|
|
2018
|
|
2017
|
|
||||||||||||
|
(in thousands, except percentages, pet and per pet data)
|
|
|
||||||||||||||||||
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Subscription business
|
$
|
67,421
|
|
|
$
|
56,493
|
|
|
19
|
%
|
|
$
|
192,805
|
|
|
$
|
159,363
|
|
|
21
|
%
|
Other business
|
10,743
|
|
|
6,625
|
|
|
62
|
|
|
28,511
|
|
|
16,759
|
|
|
70
|
|
||||
Total revenue
|
$
|
78,164
|
|
|
$
|
63,118
|
|
|
24
|
|
|
$
|
221,316
|
|
|
$
|
176,122
|
|
|
26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Percentage of Revenue by Segment:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Subscription business
|
86
|
%
|
|
90
|
%
|
|
|
|
87
|
%
|
|
90
|
%
|
|
|
||||||
Other business
|
14
|
|
|
10
|
|
|
|
|
13
|
|
|
10
|
|
|
|
||||||
Total revenue
|
100
|
|
|
100
|
|
|
|
|
100
|
|
|
100
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Total pets enrolled (at period end)
|
497,942
|
|
|
404,069
|
|
|
23
|
|
|
497,942
|
|
|
404,069
|
|
|
23
|
|
||||
Total subscription pets enrolled (at period end)
|
416,527
|
|
|
359,102
|
|
|
16
|
|
|
416,527
|
|
|
359,102
|
|
|
16
|
|
||||
Monthly average revenue per pet
|
$
|
54.55
|
|
|
$
|
52.95
|
|
|
3
|
|
|
$
|
54.06
|
|
|
$
|
51.67
|
|
|
5
|
|
Average monthly retention
|
98.61
|
%
|
|
98.61
|
%
|
|
|
|
98.61
|
%
|
|
98.61
|
%
|
|
|
|
Three Months Ended September 30,
|
|
% Change
|
|
Nine Months Ended September 30,
|
|
% Change
|
||||||||||||||
|
2018
|
|
2017
|
|
|
2018
|
|
2017
|
|
||||||||||||
|
(in thousands, except percentages, pet and per pet data)
|
|
|
||||||||||||||||||
Cost of Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Subscription business:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Veterinary invoice expense
|
$
|
48,285
|
|
|
$
|
39,761
|
|
|
21
|
%
|
|
$
|
139,868
|
|
|
$
|
113,748
|
|
|
23
|
%
|
Other cost of revenue
|
6,468
|
|
|
5,454
|
|
|
19
|
|
|
18,232
|
|
|
15,304
|
|
|
19
|
|
||||
Total cost of revenue
|
$
|
54,753
|
|
|
$
|
45,215
|
|
|
21
|
|
|
$
|
158,100
|
|
|
$
|
129,052
|
|
|
23
|
|
Gross profit
|
$
|
12,668
|
|
|
$
|
11,278
|
|
|
12
|
|
|
$
|
34,705
|
|
|
$
|
30,311
|
|
|
14
|
|
Other business:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Veterinary invoice expense
|
6,018
|
|
|
3,692
|
|
|
63
|
|
|
16,328
|
|
|
9,901
|
|
|
65
|
|
||||
Other cost of revenue
|
3,649
|
|
|
2,404
|
|
|
52
|
|
|
9,727
|
|
|
5,856
|
|
|
66
|
|
||||
Total cost of revenue
|
$
|
9,667
|
|
|
$
|
6,096
|
|
|
59
|
|
|
$
|
26,055
|
|
|
$
|
15,757
|
|
|
65
|
|
Gross profit
|
$
|
1,076
|
|
|
$
|
529
|
|
|
103
|
|
|
$
|
2,456
|
|
|
$
|
1,002
|
|
|
145
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Percentage of Revenue by Segment:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Subscription business:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Veterinary invoice expense
|
71
|
%
|
|
70
|
%
|
|
|
|
73
|
%
|
|
71
|
%
|
|
|
||||||
Other cost of revenue
|
10
|
|
|
10
|
|
|
|
|
9
|
|
|
10
|
|
|
|
||||||
Total cost of revenue
|
81
|
|
|
80
|
|
|
|
|
82
|
|
|
81
|
|
|
|
||||||
Gross profit
|
19
|
|
|
20
|
|
|
|
|
18
|
|
|
19
|
|
|
|
||||||
Other business:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Veterinary invoice expense
|
56
|
|
|
56
|
|
|
|
|
57
|
|
|
59
|
|
|
|
||||||
Other cost of revenue
|
34
|
|
|
36
|
|
|
|
|
34
|
|
|
35
|
|
|
|
||||||
Total cost of revenue
|
90
|
|
|
92
|
|
|
|
|
91
|
|
|
94
|
|
|
|
||||||
Gross profit
|
10
|
|
|
8
|
|
|
|
|
9
|
|
|
6
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Total pets enrolled (at period end)
|
497,942
|
|
|
404,069
|
|
|
23
|
|
|
497,942
|
|
|
404,069
|
|
|
23
|
|
||||
Total subscription pets enrolled (at period end)
|
416,527
|
|
|
359,102
|
|
|
16
|
|
|
416,527
|
|
|
359,102
|
|
|
16
|
|
||||
Monthly average revenue per pet
|
$
|
54.55
|
|
|
$
|
52.95
|
|
|
3
|
|
|
$
|
54.06
|
|
|
$
|
51.67
|
|
|
5
|
|
|
Three Months Ended September 30,
|
|
% Change
|
|
Nine Months Ended September 30,
|
|
% Change
|
||||||||||||||
|
2018
|
|
2017
|
|
|
2018
|
|
2017
|
|
||||||||||||
|
(in thousands, except percentages)
|
|
|
||||||||||||||||||
Technology and development
|
$
|
2,299
|
|
|
$
|
2,471
|
|
|
(7
|
)%
|
|
$
|
6,761
|
|
|
$
|
7,196
|
|
|
(6
|
)%
|
Percentage of total revenue
|
3
|
%
|
|
4
|
%
|
|
|
|
3
|
%
|
|
4
|
%
|
|
|
|
Three Months Ended September 30,
|
|
% Change
|
|
Nine Months Ended September 30,
|
|
% Change
|
||||||||||||||
|
2018
|
|
2017
|
|
|
2018
|
|
2017
|
|
||||||||||||
|
(in thousands, except percentages)
|
|
|
||||||||||||||||||
General and administrative
|
$
|
4,174
|
|
|
$
|
4,017
|
|
|
4
|
%
|
|
$
|
13,242
|
|
|
$
|
12,274
|
|
|
8
|
%
|
Percentage of total revenue
|
5
|
%
|
|
6
|
%
|
|
|
|
6
|
%
|
|
7
|
%
|
|
|
|
Three Months Ended September 30,
|
|
% Change
|
|
Nine Months Ended September 30,
|
|
% Change
|
||||||||||||||
|
2018
|
|
2017
|
|
|
2018
|
|
2017
|
|
||||||||||||
|
(in thousands, except percentages, pet and per pet data)
|
|
|
||||||||||||||||||
Sales and marketing
|
$
|
6,365
|
|
|
$
|
4,862
|
|
|
31
|
%
|
|
$
|
18,005
|
|
|
$
|
13,323
|
|
|
35
|
%
|
Subscription Business:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Total subscription pets enrolled (at period end)
|
416,527
|
|
|
359,102
|
|
|
16
|
|
|
416,527
|
|
|
359,102
|
|
|
16
|
|
||||
Average pet acquisition cost (PAC)
|
$
|
155
|
|
|
$
|
151
|
|
|
3
|
|
|
$
|
157
|
|
|
$
|
141
|
|
|
11
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
|
(in thousands)
|
||||||||||||||
Interest expense
|
$
|
336
|
|
|
$
|
124
|
|
|
$
|
887
|
|
|
$
|
370
|
|
Other (income) expense, net
|
(628
|
)
|
|
(99
|
)
|
|
(1,071
|
)
|
|
(1,239
|
)
|
||||
Total other (income) expense, net
|
$
|
(292
|
)
|
|
$
|
25
|
|
|
$
|
(184
|
)
|
|
$
|
(869
|
)
|
|
Nine Months Ended September 30,
|
||||||
|
2018
|
|
2017
|
||||
Net cash provided by operating activities
|
$
|
9,016
|
|
|
$
|
6,689
|
|
Net cash used in investing activities
|
(64,829
|
)
|
|
(8,433
|
)
|
||
Net cash provided by financing activities
|
65,677
|
|
|
2,920
|
|
||
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash, net
|
(93
|
)
|
|
436
|
|
||
Net change in cash, cash equivalents and restricted cash
|
$
|
9,771
|
|
|
$
|
1,612
|
|
•
|
the continued positive market presence, reputation and growth of our company and of the referral sources;
|
•
|
the effectiveness of referral sources;
|
•
|
the decision of any such referral source to support one or more of our competitors;
|
•
|
the interest of the referral sources’ customers or clients in our subscription;
|
•
|
the relationship and level of trust between Territory Partners and veterinarians, and between us and the referral source;
|
•
|
the percentage of the referral sources’ customers or clients that submit applications or use trial certificates to enroll through our website or contact center;
|
•
|
our ability to implement or maintain any marketing programs, including trial certificates, in any jurisdiction; and
|
•
|
our ability to work with the referral source to implement any changes in our marketing initiatives, including website changes, infrastructure and technology and other programs and initiatives necessary to generate positive consumer experiences.
|
•
|
improve our market penetration through efficient and effective sales and marketing programs to attract new members;
|
•
|
maintain high retention rates;
|
•
|
increase the lifetime value per pet to, in turn, enable us to spend more on sales and marketing programs;
|
•
|
maintain positive relationships with veterinarians and other referral sources, and convince them to recommend our subscription;
|
•
|
maintain positive relationships with and increase the number and efficiency of Territory Partners;
|
•
|
continue to offer a superior value with competitive features and rates;
|
•
|
accurately price our subscriptions in relation to actual member costs and operating expenses and achieve required regulatory approval for pricing changes;
|
•
|
provide our members with superior member service, including timely and efficient payment of veterinary invoices, and by recruiting, integrating and retaining skilled and experienced personnel who can appropriately and efficiently review veterinary invoices and process payments;
|
•
|
generate new and maintain existing relationships and programs in our other business segment;
|
•
|
recruit, integrate and retain skilled, qualified and experienced sales department professionals who can demonstrate our value proposition to new and existing members;
|
•
|
react to changes in technology and challenges in the industry, including from existing and new competitors;
|
•
|
increase awareness of and positive associations with our brand; and
|
•
|
successfully respond to any regulatory matters and defend any litigation.
|
•
|
the competitiveness of our subscription, including its perceived value, simplicity, and fairness;
|
•
|
changes in consumer shopping behaviors due to circumstances outside of our control, such as economic conditions and consumers’ ability or willingness to pay for our product;
|
•
|
the quality of and changes to the consumer experience when speaking with us on the phone or using our website;
|
•
|
regulatory requirements, including those that make the experience on our website cumbersome or difficult to navigate or that hinder our ability to speak with potential members quickly and in a way that is conducive to converting leads, enrolling new pets, and/or resolving member concerns;
|
•
|
system failures or interruptions in the operation of our abilities to write policies or operate our website or contact center; and
|
•
|
changes in the mix of consumers who are referred to us through various member acquisition channels, such as veterinary referrals, existing members adding a pet and referring their friends and family members and other third-party referrals and direct-to-consumer acquisition channels.
|
•
|
the efficacy and viability of our sales and marketing programs;
|
•
|
the perceived value of our subscription;
|
•
|
quality of service provided, including the fairness, ease and timeliness of reviewing and paying veterinary invoices;
|
•
|
actions of our competitors, Territory Partners, veterinarians and other referral sources;
|
•
|
positive or negative publicity, including regulatory pronouncements and material on the Internet or social media;
|
•
|
regulatory and other government-related developments; and
|
•
|
litigation-related developments.
|
•
|
our ability to retain our current members and grow our member base;
|
•
|
the level of operating expense we elect to incur related to sales and marketing and technology and development initiatives that are discretionary in nature;
|
•
|
the effectiveness of our sales and marketing programs;
|
•
|
our ability to improve veterinarians’ and other third-parties’ willingness to recommend our subscription;
|
•
|
the timing, volume and amount of veterinary invoices and the adequacy of our related reserve;
|
•
|
our ability to accurately price our subscription and achieve required regulatory pricing approvals;
|
•
|
regulatory limitations or other constraints on our ability or our willingness to implement pricing changes;
|
•
|
the level of demand for and cost of our subscription or competing products;
|
•
|
fluctuations in applicable foreign currency exchange rates;
|
•
|
the perceived value of our subscription to veterinarians and pet owners;
|
•
|
spending decisions by our members and prospective members;
|
•
|
our costs and expenses, including pet acquisition costs and costs to pay and process veterinary invoices;
|
•
|
our ability to expand the scope and efficiency of our Territory Partner group;
|
•
|
our ability to effectively manage our growth;
|
•
|
the effects of increased competition in our business;
|
•
|
our ability to keep pace with changes in technology and our competitors;
|
•
|
the impact of any security incidents or service interruptions;
|
•
|
costs associated with defending any regulatory action or litigation or with enforcing our intellectual property, contractual or other rights;
|
•
|
the impact of economic conditions on our revenue and expenses; and
|
•
|
changes in government regulation affecting our business.
|
•
|
we may be unable to maintain or secure favorable relationships with strategic partners;
|
•
|
our strategic partners may not be successful in creating leads;
|
•
|
we may be unable to convert leads from our strategic partners into enrolled pets;
|
•
|
our strategic partners could terminate their relationships with us;
|
•
|
we may not experience a consistent correlation between revenues and expenditures related to the partnership, and
|
•
|
bad publicity and other issues faced by our strategic partners could negatively impact us.
|
•
|
reducing the availability of our cash flow for our operations, capital expenditures, future business opportunities and other purposes;
|
•
|
limiting our flexibility in planning for, or reacting to, changes in our business and the industries in which we operate, which could place us at a competitive disadvantage compared to our competitors that may have less debt;
|
•
|
limiting our ability to borrow additional funds; and
|
•
|
increasing our vulnerability to general adverse economic and industry conditions.
|
•
|
regulatory rules and practices, foreign exchange controls, tariffs, tax laws and treaties that are different than those we operate under in the United States, Canada and Puerto Rico and that carry a greater risk of unexpected changes;
|
•
|
the costs and resources required to modify our technology and sell our subscription in non-English speaking countries;
|
•
|
the costs and resources required to modify our subscription appropriately to suit the needs and expectations of residents and veterinarians in such foreign countries;
|
•
|
our data analytics platform may have limited applicability in foreign countries, which may impact our ability to develop adequate underwriting criteria and accurately price subscriptions in such countries;
|
•
|
increased expenses incurred in establishing and maintaining office space and equipment for our international operations;
|
•
|
technological incompatibility;
|
•
|
fluctuations in exchange rates between the U.S. dollar and foreign currencies in markets where we do business;
|
•
|
difficulties in attracting and retaining personnel with experience in international operations;
|
•
|
difficulties in modifying our business model in a manner suitable for any particular foreign country, including any modifications to our Territory Partner model to the extent we determine that our existing model is not suitable for use in foreign countries;
|
•
|
our lack of experience in marketing to consumers and veterinarians, and encouraging online marketing, in foreign countries;
|
•
|
our relative lack of industry connections in many foreign countries;
|
•
|
difficulties in managing operations due to language barriers, distance and time zone differences, staffing, cultural differences and business infrastructure constraints, including difficulty in obtaining foreign and domestic visas;
|
•
|
application of foreign laws and regulations to us, including more stringent or materially different insurance, employment, consumer and data protection laws;
|
•
|
the uncertainty of protection for intellectual property rights in some countries;
|
•
|
greater risk of a failure of foreign employees to comply with applicable U.S. and foreign laws, including antitrust regulations, the U.S. Foreign Corrupt Practices Act and any trade regulations ensuring fair trade practices; and
|
•
|
general economic and political conditions in these foreign markets.
|
•
|
No Action Level: Insurer’s total adjusted capital is equal to or greater than 200% of the Authorized Control Level.
|
•
|
Company Action Level: Insurer’s total adjusted capital is less than 200% but greater than 150% of the Authorized Control Level. When at this level, an insurer must prepare and submit a financial plan to the NY DFS for review and approval. Generally, a risk-based capital plan would identify the conditions that contributed to the Company Action Level and include the insurer’s proposed plans for increasing its risk-based capital in order to satisfy the No Action Level. The failure to provide the NY DFS with a risk-based capital plan on a timely basis or the inability of the NY DFS and the insurer to mutually agree on an appropriate risk-based capital plan could trigger a Regulatory Action Level outcome, subject to the insurer’s right to a hearing on the issue.
|
•
|
Regulatory Action Level: Insurer’s total adjusted capital is less than 150% but greater than 100% of the Authorized Control Level. When at this level, an insurer generally must provide a risk-based capital plan to the NY DFS and be subject to examination or analysis by the NY DFS to the extent it deems necessary, including such corrective actions as the NY DFS may require.
|
•
|
Authorized Control Level: Insurer’s total adjusted capital is less than 100% but greater than 70% of the Authorized Control Level. At this level, the NY DFS generally could take remedial actions that it determines necessary to protect the insurer’s assets, including placing the insurer under regulatory control.
|
•
|
Mandatory Control Level: Insurer’s total adjusted capital is less than 70% of the Authorized Control Level. At this level, the NY DFS generally is required to take steps to place the insurer under regulatory control, even if the insurer is still solvent.
|
•
|
grant and revoke licenses to transact insurance business;
|
•
|
conduct inquiries into the insurance-related activities and conduct of agents and agencies and others in the sales, marketing and promotional channels;
|
•
|
require and regulate disclosure in connection with the sale and solicitation of insurance policies;
|
•
|
authorize how, by which personnel and under what circumstances insurance premiums can be quoted and published and an insurance policy sold;
|
•
|
regulate which entities or individuals can be incentivized and the circumstances under which this may occur;
|
•
|
regulate the content of insurance-related advertisements, including web pages, and other marketing practices;
|
•
|
approve policy forms, require specific benefits and benefit levels and regulate premium rates;
|
•
|
impose fines and other penalties; and
|
•
|
impose continuing education requirements.
|
•
|
variations in our operating results, earnings per share, cash flows from operating activities, and key operating metrics, and how those results compare to analyst expectations;
|
•
|
forward-looking guidance that we provide to the public and industry and financial analysts related to future revenue and profitability, and any change in that guidance or our failure to achieve the results reflected in that guidance;
|
•
|
the net increases in the number of members, either independently or as compared with published expectations of industry, financial or other analysts that cover our company;
|
•
|
changes in the estimates of our operating results or changes in recommendations by securities analysts that elect to follow our common stock;
|
•
|
announcements of changes to our subscription, strategic alliances or significant agreements by us or by our competitors;
|
•
|
announcements by us or by our competitors of mergers or other strategic acquisitions, or rumors of such transactions involving us or our competitors;
|
•
|
recruitment or departure of key personnel;
|
•
|
the economy as a whole and market conditions in our industry;
|
•
|
trading activity by a limited number of stockholders who together beneficially own a majority of our outstanding common stock;
|
•
|
the number of shares of our stock trading on a regular basis; and
|
•
|
any other factors discussed in these risk factors.
|
•
|
establish a classified board of directors so that not all members of our board are elected at one time;
|
•
|
permit only the board of directors to establish the number of directors and fill vacancies on the board;
|
•
|
provide that directors may only be removed “for cause” and only with the approval of two-thirds of our stockholders;
|
•
|
require super-majority voting to amend some provisions in our restated certificate of incorporation and restated bylaws;
|
•
|
authorize the issuance of “blank check” preferred stock that our board could use to implement a stockholder rights plan (also known as a “poison pill”);
|
•
|
eliminate the ability of our stockholders to call special meetings of stockholders;
|
•
|
prohibit stockholder action by written consent, which requires all stockholder actions to be taken at a meeting of our stockholders;
|
•
|
prohibit cumulative voting; and
|
•
|
establish advance notice requirements for nominations for election to our board or for proposing matters that can be acted upon by stockholders at annual stockholder meetings.
|
|
|
|
|
|
TRUPANION, INC.
|
|
|
|
Date: November 8, 2018
|
|
/s/ Darryl Rawlings
|
|
|
Darryl Rawlings
Chief Executive Officer and President
(Principal Executive Officer)
|
|
|
|
Date: November 8, 2018
|
|
/s/ Tricia Plouf
|
|
|
Tricia Plouf
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
|
|
|
|
Incorporated by Reference
|
|
Filed/Furnished
|
||||||
Number
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Exhibit Filing Date
|
|
Herewith
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.2
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.2
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.1*
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.2*
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document - the instance does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document.
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Labels Linkbase Document.
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
|
|
|
|
|
|
|
|
X
|
*
|
This certification is deemed not filed for purpose of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
|
1.
|
Value of Compensation (“Award Values”)
|
a.
|
Non-Employee Board of Director Compensation:
|
i.
|
Annual value of compensation for all Non-Employee Board of Directors (“Board”) members: $75,000
|
b.
|
Additional Committee Compensation (to be granted separate from Non-Employee Board of Director Compensation):
|
i.
|
Audit Committee chair: Annual value of $15,000
|
ii.
|
Compensation Committee chair: Annual value of $10,000
|
2.
|
Cash and Equity Awards
|
a.
|
Non-Employee Board members will receive 100% of his or her compensation under this Compensation Program for Non-Employee Directors (this “Compensation Program”) pursuant to the Company’s 2014 Equity Incentive Plan (the “Plan”), in the form of stock options (“Options”) or restricted stock units (“RSUs”, and together with Options, “Awards”); provided, however, that on an annual basis each such Board member may elect to take 50% of his or her compensation as cash compensation by submitting an election form (“Election Form”), attached hereto as Exhibit A (subject to the Board’s ownership guidelines). Such election must be submitted to the Compensation Committee chairperson and Company’s General Counsel and must be made prior to the beginning of any calendar year with respect to which such compensation is first payable (regardless of when paid) and, in the case of Awards, first granted, and cannot be changed during the year (the actual date of such election, if any, the “Election Date”). In the absence of such an election, Awards will comprise 100% of such Board member’s compensation under this Compensation Program.
|
b.
|
Any cash compensation under this Compensation Program will be paid quarterly.
|
c.
|
Award Values will be approved at the first regularly scheduled Board meeting in any calendar year, or in the case of a new member of the Board, at the Board meeting in which such member is elected or on the first regularly scheduled meeting that follows such member’s election (the “Award Approval”). Awards will be granted in the next open trading window following the Award Approval (“Annual Grant Date”).
|
d.
|
Annual Awards will vest in four quarterly installments on March 31st, June 30th, September 30th, and December 31st (each a “Vest Date”).
|
e.
|
Members of the Board and committee chairpersons will be entitled to compensation granted under this Compensation Program at the end of the quarter following the grant date and for complete quarters of service thereafter.
|
f.
|
Awards granted under this Compensation Program that are unvested at the time of resignation or other termination from the Board will be forfeited. Similarly, no cash compensation will be paid following the effective date of a directors’ resignation or other termination from the Board.
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Trupanion, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Trupanion, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
1.
|
The Quarterly Report of Trupanion, Inc. on Form 10-Q for the quarterly period ended September 30, 2017, as filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Trupanion, Inc.
|
1.
|
The Quarterly Report of Trupanion, Inc. on Form 10-Q for the quarterly period ended September 30, 2017, as filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Trupanion, Inc.
|